NWAM LLC’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

NWAM LLC’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-14,926	Closed	-$1.47M	–	648
2024 Q3	$1.47M	Buy	+14,926	New	+$1.47M	0.09%	214
2024 Q2	–	Sell	-21,628	Closed	-$1.96M	–	549
2024 Q1	$1.96M	Buy	+21,628	New	+$2.01M	0.16%	132
2023 Q3	–	Sell	-2,684	Closed	-$223K	–	554
2023 Q2	$223K	Buy	+2,684	New	+$224K	0.02%	486

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

NWAM LLC's XBI Position: Q4 2024 in Review

NWAM LLC sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2024, closing a stake of 14,926 shares — an estimated $1.47M sold.

NWAM LLC first reported a position in XBI in Q2 2023 and held it in 3 quarters. The position peaked at $1.96M in Q1 2024. 738 funds tracked by Wall St. Rank hold XBI as of Q4 2024.

NWAM LLC reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2024 after selling out during the quarter.
NWAM LLC sold 14,926 State Street SPDR S&P Biotech ETF shares in Q4 2024, an estimated $1.47M.
NWAM LLC first reported a position in State Street SPDR S&P Biotech ETF in Q2 2023 and held it in 3 quarters.
NWAM LLC's State Street SPDR S&P Biotech ETF position peaked at $1.96M in Q1 2024.
738 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2024.

Based on NWAM LLC's 13F filing for Q4 2024, filed 5 Feb 2025.